Literature DB >> 20566646

Synthetic triterpenoids target the Arp2/3 complex and inhibit branched actin polymerization.

Ciric To1, Brian H Shilton, Gianni M Di Guglielmo.   

Abstract

Synthetic triterpenoids are anti-tumor agents that affect numerous cellular functions including apoptosis and growth inhibition. Here, we used mass spectrometric and protein array approaches and uncovered that triterpenoids associate with proteins of the actin cytoskeleton, including actin-related protein 3 (Arp3). Arp3, a subunit of the Arp2/3 complex, is involved in branched actin polymerization and the formation of lamellipodia. 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO)-Im and CDDO-Me were observed to 1) inhibit the localization of Arp3 and actin at the leading edge of cells, 2) abrogate cell polarity, and 3) inhibit Arp2/3-dependent branched actin polymerization. We confirmed our drug effects with siRNA targeting of Arp3 and observed a decrease in Rat2 cell migration. Taken together, our data suggest that synthetic triterpenoids target Arp3 and branched actin polymerization to inhibit cell migration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20566646      PMCID: PMC2934661          DOI: 10.1074/jbc.M110.103036

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Immunomodulatory activity of synthetic triterpenoids: inhibition of lymphocyte proliferation, cell-mediated cytotoxicity, and cytokine gene expression through suppression of NF-kappaB.

Authors:  Xiaohua Gao; Dorrah Deeb; Andrew Danyluk; Joseph Media; Yongbo Liu; Scott A Dulchavsky; Subhash C Gautam
Journal:  Immunopharmacol Immunotoxicol       Date:  2008       Impact factor: 2.730

Review 2.  Regulation of actin assembly associated with protrusion and adhesion in cell migration.

Authors:  Christophe Le Clainche; Marie-France Carlier
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

3.  Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.

Authors:  Rajesh K Thimmulappa; Ralph J Fuchs; Deepti Malhotra; Catherine Scollick; Kassim Traore; Jay H Bream; Michael A Trush; Karen T Liby; Michael B Sporn; Thomas W Kensler; Shyam Biswal
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

4.  The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid-imidazolide alters transforming growth factor beta-dependent signaling and cell migration by affecting the cytoskeleton and the polarity complex.

Authors:  Ciric To; Sarang Kulkarni; Tony Pawson; Tadashi Honda; Gordon W Gribble; Michael B Sporn; Jeffrey L Wrana; Gianni M Di Guglielmo
Journal:  J Biol Chem       Date:  2008-02-18       Impact factor: 5.157

5.  The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.

Authors:  Xiaoyang Ling; Marina Konopleva; Zhihong Zeng; Vivian Ruvolo; L Clifton Stephens; Wendy Schober; Teresa McQueen; Martin Dietrich; Timothy L Madden; Michael Andreeff
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

6.  NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis.

Authors:  Soona Shin; Nobunao Wakabayashi; Vikas Misra; Shyam Biswal; Gum Hwa Lee; Elin S Agoston; Masayuki Yamamoto; Thomas W Kensler
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

7.  CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells.

Authors:  Dorrah Deeb; Xiaohua Gao; Scott A Dulchavsky; Subhash C Gautam
Journal:  Anticancer Res       Date:  2007 Sep-Oct       Impact factor: 2.480

8.  Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.

Authors:  Xiaohua Gao; Dorrah Deeb; Hao Jiang; Yongbo Liu; Scott A Dulchavsky; Subhash C Gautam
Journal:  J Neurooncol       Date:  2007-03-15       Impact factor: 4.130

Review 9.  Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.

Authors:  Karen T Liby; Mark M Yore; Michael B Sporn
Journal:  Nat Rev Cancer       Date:  2007-04-19       Impact factor: 60.716

10.  c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells.

Authors:  Wei Zou; Shuzhen Chen; Xiangguo Liu; Ping Yue; Michael B Sporn; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Biol Ther       Date:  2007-07-19       Impact factor: 4.742

View more
  16 in total

1.  Small molecule grp94 inhibitors block dengue and Zika virus replication.

Authors:  Hussin A Rothan; Yongwang Zhong; Mark A Sanborn; Teow Chong Teoh; Jingjing Ruan; Rohana Yusof; Jun Hang; Mark J Henderson; Shengyun Fang
Journal:  Antiviral Res       Date:  2019-08-14       Impact factor: 5.970

Review 2.  Nucleating actin for invasion.

Authors:  Alexander Nürnberg; Thomas Kitzing; Robert Grosse
Journal:  Nat Rev Cancer       Date:  2011-02-10       Impact factor: 60.716

3.  Structural characterization and computer-aided optimization of a small-molecule inhibitor of the Arp2/3 complex, a key regulator of the actin cytoskeleton.

Authors:  Andrew W Baggett; Zoe Cournia; Min Suk Han; George Patargias; Adam C Glass; Shih-Yuan Liu; Brad J Nolen
Journal:  ChemMedChem       Date:  2012-05-23       Impact factor: 3.466

4.  Polarized actin structural dynamics in response to cyclic uniaxial stretch.

Authors:  Lawrence Huang; Brian P Helmke
Journal:  Cell Mol Bioeng       Date:  2015-03       Impact factor: 2.321

5.  Deregulation of focal adhesion formation and cytoskeletal tension due to loss of A-type lamins.

Authors:  Tobias D J Corne; Tom Sieprath; Jonathan Vandenbussche; Danahe Mohammed; Mariska Te Lindert; Kris Gevaert; Sylvain Gabriele; Katarina Wolf; Winnok H De Vos
Journal:  Cell Adh Migr       Date:  2016-11-16       Impact factor: 3.405

6.  Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability.

Authors:  Phillip R Lazzara; Brian P David; Aparna Ankireddy; Benjamin G Richardson; Katherine Dye; Kiira M Ratia; Sekhar P Reddy; Terry W Moore
Journal:  J Med Chem       Date:  2019-11-14       Impact factor: 7.446

Review 7.  Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.

Authors:  Karen T Liby; Michael B Sporn
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

8.  Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling.

Authors:  Angelika F Winkel; Christian K Engel; Daniel Margerie; Aimo Kannt; Hauke Szillat; Heiner Glombik; Christopher Kallus; Sven Ruf; Stefan Güssregen; Jens Riedel; Andreas W Herling; Andreas von Knethen; Andreas Weigert; Bernhard Brüne; Dieter Schmoll
Journal:  J Biol Chem       Date:  2015-10-12       Impact factor: 5.157

9.  The apical ES-BTB-BM functional axis is an emerging target for toxicant-induced infertility.

Authors:  Hin-Ting Wan; Dolores D Mruk; Chris K C Wong; C Yan Cheng
Journal:  Trends Mol Med       Date:  2013-05-02       Impact factor: 11.951

Review 10.  New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress.

Authors:  Michael B Sporn; Karen T Liby; Mark M Yore; Liangfeng Fu; Justin M Lopchuk; Gordon W Gribble
Journal:  J Nat Prod       Date:  2011-02-10       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.